These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 25178341)

  • 1. Relevant infrastructural alterations in a pancreatic neuroendocrine tumor: an insulinoma case.
    Mirancea GV; Moroşanu AM; Carniciu S; Dima S; Bacalbaşa N; Popescu I; Ionescu-Tîrgovişte C; Mirancea N
    Rom J Morphol Embryol; 2014; 55(2 Suppl):659-68. PubMed ID: 25178341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relevant infrastructural alterations in invasive pancreatic ductal adenocarcinoma.
    Constantin VD; Mirancea GV; Moroşanu AM; Mirancea N
    Rom J Morphol Embryol; 2015; 56(1):207-22. PubMed ID: 25826507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transformation of nonfunctioning pancreatic tumor into malignant insulinoma after 3 years: an uncommon clinical course of insulinoma.
    Arslan MS; Ozbek M; Karakose M; Tutal E; Ucan B; Yilmazer D; Dilli A; Gultekin SS; Cakal E; Delibasi T
    Arch Endocrinol Metab; 2015 Jun; 59(3):270-2. PubMed ID: 26154097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular pancreatic lesions: spectrum of imaging findings of malignant masses and mimics with pathologic correlation.
    Bhosale PR; Menias CO; Balachandran A; Tamm EP; Charnsangavej C; Francis IR; Elsayes KM
    Abdom Imaging; 2013 Aug; 38(4):802-17. PubMed ID: 22968429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of somatostatin analog and meta-iodobenzylguanidine radionuclides in the diagnosis and localization of advanced neuroendocrine tumors.
    Kaltsas G; Korbonits M; Heintz E; Mukherjee JJ; Jenkins PJ; Chew SL; Reznek R; Monson JP; Besser GM; Foley R; Britton KE; Grossman AB
    J Clin Endocrinol Metab; 2001 Feb; 86(2):895-902. PubMed ID: 11158063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical strategy in the treatment of pancreatic neuroendocrine tumors.
    Falconi M; Bettini R; Boninsegna L; Crippa S; Butturini G; Pederzoli P
    JOP; 2006 Jan; 7(1):150-6. PubMed ID: 16407638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pancreatic neuroendocrine tumors: radiographic calcifications correlate with grade and metastasis.
    Poultsides GA; Huang LC; Chen Y; Visser BC; Pai RK; Jeffrey RB; Park WG; Chen AM; Kunz PL; Fisher GA; Norton JA
    Ann Surg Oncol; 2012 Jul; 19(7):2295-303. PubMed ID: 22396008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ribosome-lamellae complexes in a symptomatic insulinoma. An ultrastructural study.
    Perez-Atayde AR; Hartman AS; Seiler MW
    Arch Pathol Lab Med; 1982 May; 106(5):221-3. PubMed ID: 6280636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pancreatic imaging mimics: part 2, pancreatic neuroendocrine tumors and their mimics.
    Raman SP; Hruban RH; Cameron JL; Wolfgang CL; Fishman EK
    AJR Am J Roentgenol; 2012 Aug; 199(2):309-18. PubMed ID: 22826391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pedunculated insulinoma on the anterior border of the head of the pancreas: an unusual location to be aware of.
    Sebbag-Sfez D; Berrod JL; Palazzo L; Zins M
    Diagn Interv Imaging; 2013 Mar; 94(3):327-9. PubMed ID: 23352878
    [No Abstract]   [Full Text] [Related]  

  • 11. [Ultrastructure and immunohistology of insulinoma].
    Dubiel-Bigaj M; Legutko J; Dabroś W; Pietroń M; Stachura J
    Patol Pol; 1987; 38(3-4):301-15. PubMed ID: 2832814
    [No Abstract]   [Full Text] [Related]  

  • 12. Pancreatic insulinoma.
    Tseng LJ; Jao YT; Liu SM; Yang TM; Tsai CC; Mo LR
    Gastrointest Endosc; 2003 Jul; 58(1):97-8. PubMed ID: 12838231
    [No Abstract]   [Full Text] [Related]  

  • 13. Fluorine-18-L-dihydroxyphenylalanine (18F-DOPA) positron emission tomography as a tool to localize an insulinoma or beta-cell hyperplasia in adult patients.
    Kauhanen S; Seppänen M; Minn H; Gullichsen R; Salonen A; Alanen K; Parkkola R; Solin O; Bergman J; Sane T; Salmi J; Välimäki M; Nuutila P
    J Clin Endocrinol Metab; 2007 Apr; 92(4):1237-44. PubMed ID: 17227804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Magnetic resonance diagnosis of insulinoma].
    García Quintanilla F; Forsbach G; López Betancourt G
    Rev Gastroenterol Mex; 1996; 61(1):43-6. PubMed ID: 8685591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sporadic insulinoma in a 10-year-old boy: a case report and literature review.
    Abu-Zaid A; Alghuneim LA; Metawee MT; Elkabbani RO; Almana H; Amin T; Azzam A
    JOP; 2014 Jan; 15(1):53-7. PubMed ID: 24413786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small serotonin-producing neuroendocrine tumor of the pancreas associated with pancreatic duct obstruction.
    Kawamoto S; Shi C; Hruban RH; Choti MA; Schulick RD; Fishman EK; Siegelman SS
    AJR Am J Roentgenol; 2011 Sep; 197(3):W482-8. PubMed ID: 21862776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Embolization of an insulinoma of the pancreas with trisacryl gelatin microspheres as definitive treatment.
    Rott G; Biggemann M; Pfohl M
    Cardiovasc Intervent Radiol; 2008; 31(3):659-62. PubMed ID: 17922161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnosis of insulinoma of the pancreas by computed tomography ].
    Buck J; Binder JP
    Radiologe; 1982 Jun; 22(6):279-82. PubMed ID: 6289374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful preoperative localization of a small pancreatic insulinoma by diffusion-weighted MRI.
    Anaye A; Mathieu A; Closset J; Bali MA; Metens T; Matos C
    JOP; 2009 Sep; 10(5):528-31. PubMed ID: 19734630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Octreoscan SPET evaluation in the diagnosis of pancreas neuroendocrine tumors.
    Briganti V; Matteini M; Ferri P; Vaggelli L; Castagnoli A; Pieroni C
    Cancer Biother Radiopharm; 2001 Dec; 16(6):515-24. PubMed ID: 11789028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.